Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer.

PURPOSE Patients with head and neck squamous cell carcinoma (HNSCC) are at elevated risk of second primary malignancies (SPM), most commonly of the head and neck (HN), lung, and esophagus. Our objectives were to identify HNSCC subsite-specific differences in SPM risk and distribution and to describe trends in risk over 3 decades, before and during the era of human papillomavirus (HPV) -associated oropharyngeal SCC. METHODS Population-based cohort study of 75,087 patients with HNSCC in the Surveillance, Epidemiology, and End Results (SEER) program. SPM risk was quantified by using standardized incidence ratios (SIRs), excess absolute risk (EAR) per 10,000 person-years at risk (PYR), and number needed to observe. Trends in SPM risk were analyzed by using joinpoint log-linear regression. RESULTS In patients with HNSCC, the SIR of second primary solid tumor was 2.2 (95% CI, 2.1 to 2.2), and the EAR was 167.7 cancers per 10,000 PYR. The risk of SPM was highest for hypopharyngeal SCC (SIR, 3.5; EAR, 307.1 per 10,000 PYR) and lowest for laryngeal SCC (SIR, 1.9; EAR, 147.8 per 10,000 PYR). The most common SPM site for patients with oral cavity and oropharynx SCC was HN; for patients with laryngeal and hypopharyngeal cancer, it was the lung. Since 1991, SPM risk has decreased significantly among patients with oropharyngeal SCC (annual percentage change in EAR, -4.6%; P = .03). CONCLUSION In patients with HNSCC, the risk and distribution of SPM differ significantly according to subsite of the index cancer. Before the 1990s, hypopharynx and oropharynx cancers carried the highest excess risk of SPM. Since then, during the HPV era, SPM risk associated with oropharyngeal SCC has declined to the lowest risk level of any subsite.

[1]  Kuan-Der Lee,et al.  Impact of second primary esophageal or lung cancer on survival of patients with head and neck cancer. , 2010, Oral oncology.

[2]  F. Feng,et al.  Tobacco Use in Human Papillomavirus–Positive Advanced Oropharynx Cancer Patients Related to Increased Risk of Distant Metastases and Tumor Recurrence , 2010, Clinical Cancer Research.

[3]  Christine H Chung,et al.  Human Papillomavirus in Head and Neck Cancer: Its Role in Pathogenesis and Clinical Implications , 2009, Clinical Cancer Research.

[4]  H. Morgenstern,et al.  Total exposure and exposure rate effects for alcohol and smoking and risk of head and neck cancer: a pooled analysis of case-control studies. , 2009, American journal of epidemiology.

[5]  P. Sparén,et al.  Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: An epidemic of viral‐induced carcinoma? , 2009, International journal of cancer.

[6]  A. Olshan,et al.  Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. , 2009, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[7]  H. Morgenstern,et al.  Type of alcoholic beverage and risk of head and neck cancer--a pooled analysis within the INHANCE Consortium. , 2009, American journal of epidemiology.

[8]  L. Clegg,et al.  Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study , 2008, Cancer Causes & Control.

[9]  M. Boysen,et al.  Impact of Second Primary Tumors on Survival in Head and Neck Cancer: An Analysis of 2,063 Cases , 2008, The Laryngoscope.

[10]  E. Weiderpass,et al.  Risk of second primary cancer among patients with head and neck cancers: A pooled analysis of 13 cancer registries , 2008, International journal of cancer.

[11]  A. Cmelak,et al.  Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. , 2008, Journal of the National Cancer Institute.

[12]  Maureen M. O’Brien,et al.  Rising Incidence of Oropharyngeal Cancer and the Role of Oncogenic Human Papilloma Virus , 2007, The Laryngoscope.

[13]  E. Munck‐Wikland,et al.  Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7 , 2007, Molecular oncology.

[14]  L. Mariani,et al.  High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  R. Spreafico,et al.  Risk factors for distant metastases in head and neck squamous cell carcinoma. , 2006, Archives of otolaryngology--head & neck surgery.

[16]  J. Shah,et al.  Second primary malignancy of the aerodigestive tract in patients treated for cancer of the oral cavity and larynx , 2005, Head & neck.

[17]  A. Jemal,et al.  Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival , 2004, Cancer.

[18]  J. Califano,et al.  The molecular biology of mucosal field cancerization of the head and neck. , 2003, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[19]  B. Hankey,et al.  The surveillance, epidemiology, and end-results program database as a resource for conducting descriptive epidemiologic and clinical studies. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  M. Miura,et al.  Site specific dependency of second primary cancer in early stage head and neck squamous cell carcinoma , 2002, Cancer.

[21]  G. Snow,et al.  Second primary tumors and field cancerization in oral and oropharyngeal cancer: Molecular techniques provide new insights and definitions , 2002 .

[22]  S. Stringer,et al.  Synchronous and metachronous squamous cell carcinomas of the head and neck mucosal sites. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  Hyune-Ju Kim,et al.  Kim H-J, Fay MP, Feuer EJ, Midthune DN, ‘ Permutation tests for joinpoint regression with applications to cancer rates’. Statistics in Medicine 2000 19:335–351 , 2001 .

[24]  D. Sidransky,et al.  Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. , 2000, Journal of the National Cancer Institute.

[25]  E. Feuer,et al.  Permutation tests for joinpoint regression with applications to cancer rates. , 2000, Statistics in medicine.

[26]  M. Quer,et al.  Second neoplasm in patients with head and neck cancer , 1999, Head & neck.

[27]  E. Sturgis,et al.  Second Primary Malignancies in the Head and Neck Cancer Patient , 1995, The Annals of otology, rhinology, and laryngology.

[28]  C. Begg,et al.  Methodology for evaluating the incidence of second primary cancers with application to smoking-related cancers from the Surveillance, Epidemiology, and End Results (SEER) program. , 1995, American journal of epidemiology.

[29]  G. Gates,et al.  Meta-Analysis of Second Malignant Tumors in Head and Neck Cancer: The Case for an Endoscopic Screening Protocol , 1992, The Annals of otology, rhinology, and laryngology.

[30]  P. Rubin,et al.  Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience. , 1989, International journal of radiation oncology, biology, physics.

[31]  G. Snow,et al.  Multiple primary tumours in oral cancer. , 1986, International journal of oral and maxillofacial surgery.

[32]  G. Snow,et al.  Multiple primary tumours in laryngeal cancer , 1985, The Journal of Laryngology & Otology.

[33]  T. Sato,et al.  Multiple primary tumours in laryngeal cancer , 1985, The Journal of Laryngology & Otology.

[34]  B. Vikram.  Changing patterns of failure in advanced head and neck cancer. , 1984, Archives of otolaryngology.

[35]  J. Gluckman,et al.  Survival rates in 548 patients with multiple neoplasms of the upper aerodigestive tract , 1983, The Laryngoscope.

[36]  B. Tepperman,et al.  SECOND RESPIRATORY AND UPPER DIGESTIVE TRACT CANCERS AFTER ORAL CANCER , 1981, The Lancet.

[37]  M. Myers,et al.  Statistical methods for studying multiple primary malignant neoplasms , 1977, Cancer.

[38]  P. Trott,et al.  International Classification of Diseases for Oncology , 1977 .

[39]  D. Slaughter,et al.  “Field cancerization” in oral stratified squamous epithelium. Clinical implications of multicentric origin , 1953, Cancer.

[40]  J. Stockman.  Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer , 2012 .

[41]  R. Hoover,et al.  New malignancies among cancer survivors: SEER Cancer Registries, 1973-2000. , 2006 .

[42]  A. Neugut,et al.  Second primary tumors in patients with head and neck squamous cell carcinoma , 1995, Cancer.

[43]  Norman E. Breslow,et al.  The design and analysis of cohort studies , 1987 .

[44]  N. Breslow,et al.  Statistical methods in cancer research. Volume II--The design and analysis of cohort studies. , 1987, IARC scientific publications.

[45]  J. Fraumeni,et al.  Second cancer following cancer of the respiratory system in Connecticut, 1935-1982. , 1985, National Cancer Institute monograph.

[46]  S. Warren.  Multiple primary malignant tumors. A survey of the literature and a statistical study , 1932 .